EN
HI
Alembic Pharmaceuticals Chart
Alembic Pharmaceuticals Share Key Metrics
Volume
28310.00
Market Cap
13273.91 CR
LTQ@LTP
1@671.90
ATP
674.7
Var Margin
15.46 %
Circuit Range
540.25-810.35
Delivery %
39.31 %
Value
1.91 CR
ASM/GSM
No
Market Lot
1
Summary
At 17 Mar, 2026 | 15:08, Alembic Pharmaceuticals share price stands at ₹671.9, showing a 3.40% -0.50 for the day. The stock’s intraday movement has stayed between ₹670.00 and ₹682.45, while on a 52-week basis it has fluctuated from ₹667.05 to ₹1107.90.
In terms of trading activity, Alembic Pharmaceuticals has recorded a volume of 28310 shares, with a market capitalisation of ₹196563124. The stock’s Average Traded Price (ATP) stands at ₹67470, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,67190. The stock operates within a circuit range of ₹540.25-810.35, with a Value of ₹1.91 CR. The Delivery Percentage for the day is 39.31%. Additionally, Alembic Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Alembic Pharmaceuticals Fundamentals
View MoreP/E Ratio
21.05
P/B Ratio
2.43
Div. Yield
1.63
Sector P/E
59.21
Sector P/B
2.64
Sec. Div. Yield
0.59
Alembic Pharmaceuticals Resistance and Support
Pivot 676.42
Resistance
First Resistance
685.79
Second Resistance
696.27
Third Resistance
705.64
Support
First Support
665.94
Second Support
656.57
Third Support
646.09
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Incorporation Of Subsidiary
Alembic Pharmaceuticals incorporated a new 99.99% owned subsidiary, Alembic Pharmaceuticals (Thailand) Co., Ltd., in Thailand. This move is aimed at exploring new business opportunities and expanding the distribution of pharmaceutical products in the region.
Mar 09 2026 19:03:00
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Alembic Pharma's management will hold a one-on-one meeting with Bajaj Finserv Asset Management on March 11, 2026. This engagement in Vadodara is part of ongoing investor relations efforts.
Mar 06 2026 11:03:00
Read More
About Alembic Pharmaceuticals
NSE : 25328
BSE : 533573
ISIN : INE901L01018
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Mr. Chirayu Amin | Chairman & CEO |
| Mr. Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Acutaas Chemicals Ltd.
2297.80
132.80 (6.13%)
Onesource Specialty Pharma Ltd.
1489.60
-3.60 (0.24%)
Neuland Laboratories Ltd.
12275.00
45.00 (0.37%)
Granules India Ltd.
571.65
4.65 (0.82%)
Dr. Agarwal's Health Care Ltd.
424.75
0.90 (0.21%)
Poly Medicure Ltd.
1240.90
-14.70 (1.17%)
Jubilant Pharmova Ltd.
838.55
-1.40 (0.17%)
Caplin Point Laboratories Ltd.
1636.00
0.00 (0.00%)
Alivus Life Sciences Ltd.
936.50
11.05 (1.19%)
Concord Biotech Ltd.
1129.10
-29.00 (2.50%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 671.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 21.05. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.43. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 59.21 & 2.64 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 13273.91 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 1107.90 & 667.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
